Clinical Trials Logo

Cognitive Function Abnormal clinical trials

View clinical trials related to Cognitive Function Abnormal.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05990335 Completed - Clinical trials for Cognitive Function Abnormal

Boost Study 21270 (Cognition)

Start date: April 18, 2022
Phase: Early Phase 1
Study type: Interventional

This study is designed to to test the technical feasibility of encouraging interaction with a mobile smartphone software package (mHealth app) for training aspects of executive function and cognition.

NCT ID: NCT03189329 Completed - Clinical trials for Cognitive Function Abnormal

The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients

Start date: January 2015
Phase: Phase 4
Study type: Interventional

The investigators measured changes in cerebral oxygen saturation (rSO2) and MMSE scores after retrobulbar block performed with levobupivacaine and lidocaine in patients undergoing vitreoretinal surgery.A total of 66 patients over the age of 60 undergoing vitreoretinal surgery with a total duration of less than 1 hour were included in this prospective, double-blinded study. The patients were randomly divided into two groups: group L (5ml, 2% lidocaine) and group LB (5ml, 0.5% levobupivacaine). Bilateral rSO2 measurements were recorded before the retrobulbar block and at 1-5 minutes post-block, during the procedure, and at 10-40 minutes post-op. MMSE was performed preoperatively and postoperatively in order to evaluate short term cognitive function. Sensory and motor block durations, pain, akinesia and conjunctival feeling scores, patient-surgeon satisfaction, and complications were also recorded.